258 related articles for article (PubMed ID: 33429007)
1. Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives.
Bhardwaj V; Tan YQ; Wu MM; Ma L; Zhu T; Lobie PE; Pandey V
Cancer Lett; 2021 Apr; 502():97-107. PubMed ID: 33429007
[TBL] [Abstract][Full Text] [Related]
2. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
Chen Y; Bi F; An Y; Yang Q
J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
[TBL] [Abstract][Full Text] [Related]
3. The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC).
Malgundkar SH; Tamimi Y
Hum Genet; 2024 Feb; 143(2):107-124. PubMed ID: 38276976
[TBL] [Abstract][Full Text] [Related]
4. Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer.
Sheng R; Li X; Wang Z; Wang X
Cancer Lett; 2020 Mar; 473():139-147. PubMed ID: 31904484
[TBL] [Abstract][Full Text] [Related]
5. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs: A view to kill ovarian cancer.
Zamaraev AV; Volik PI; Sukhikh GT; Kopeina GS; Zhivotovsky B
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188584. PubMed ID: 34157315
[TBL] [Abstract][Full Text] [Related]
7. The Regulatory Roles of Long Non-Coding RNA in the Chemoresistance Process of Ovarian cancer.
Qu J; Kamal MA; Yuan C
Curr Pharm Des; 2019; 25(8):856-861. PubMed ID: 30947657
[TBL] [Abstract][Full Text] [Related]
8. Role of lncRNAs as Novel Biomarkers and Therapeutic Targets in Ovarian Cancer.
Fu LL; Li CJ; Xu Y; Li LY; Zhou X; Li DD; Chen SX; Wang FG; Zhang XY; Zheng LW
Crit Rev Eukaryot Gene Expr; 2017; 27(2):183-195. PubMed ID: 28845767
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
[TBL] [Abstract][Full Text] [Related]
10. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
[TBL] [Abstract][Full Text] [Related]
11. The Role of Long Non-Coding RNAs in Ovarian Cancer.
Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
[TBL] [Abstract][Full Text] [Related]
12. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
14. Targetable long non-coding RNAs in cancer treatments.
Chen L; Dzakah EE; Shan G
Cancer Lett; 2018 Apr; 418():119-124. PubMed ID: 29341880
[TBL] [Abstract][Full Text] [Related]
15. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
16. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
Li H; Zhou Y; Cheng H; Tian J; Yang S
Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
[TBL] [Abstract][Full Text] [Related]
17. Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.
Li Z; Dou P; Liu T; He S
Cell Physiol Biochem; 2017; 42(4):1407-1419. PubMed ID: 28715796
[TBL] [Abstract][Full Text] [Related]
18. LncRNAs in ovarian cancer.
Wang JY; Lu AQ; Chen LJ
Clin Chim Acta; 2019 Mar; 490():17-27. PubMed ID: 30553863
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion.
Zou T; Wang PL; Gao Y; Liang WT
Cancer Biomark; 2019; 25(2):133-139. PubMed ID: 30452402
[TBL] [Abstract][Full Text] [Related]
20. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
Chang H; Li B; Zhang X; Meng X
Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]